V

VENMAX DRUGS AND PHARMACEUTICA

VENMAX
Market snapshot · 2026-08-11 04:51 UTC

17.65

+₹0.45 (+2.62%)

MARKET CAP

₹15.50 Cr

STOCK P/E

84.0x

52W HIGH

₹36.96

52W LOW

₹15.56

BOOK VALUE

₹12.87

EPS

₹0.21

ROE

3.38%

SECTOR

Healthcare

DEBT/EQUITY

1.41

VOLUME

2,002

P/B RATIO

1.37x

PEG RATIO

Sector

Healthcare

Themes

Drug Manufacturers - Specialty & Generic
₹31.89₹27.90₹23.92₹19.93₹15.94VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 6.8% below historical median. Valuation is rising — currently in the fair zone (z-score: +0.22). Confidence: 50%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Fair

5Y Average

53.41

Current

85.71

Overvalued

124.05

Undervalued

19.90

EV/EBITDA
Fair

5Y Average

63.49

Current

97.37

Overvalued

123.76

Undervalued

23.66

P/S
Strongly Overvalued

5Y Average

1.06

Current

1.63

Overvalued

1.22

Undervalued

0.90

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹4.00 CrMar 2026

Latest net profit

₹0.00 CrMar 2026

Latest EPS

₹0.20Mar 2026

Net margin

0.3%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-75.0%-50.0%-25.0%0.0%25.0%0.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr₹0₹0₹1₹1₹2
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026-7.00 Cr0.00 Cr7.00 Cr14 Cr21 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹4 Cr

+1085.1%

Net Profit

₹0 Cr

-86.2%

EBITDA

₹0 Cr

-86.4%

EPS

₹0.20

-86.2%
MetricMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales01124
Expenses11124
Operating Profit-000-00
OPM %-74.61%3.1%3.47%-1.63%0.31%
Other Income100
Interest00000
Depreciation00000
Profit before tax10000
Tax %-0.43%0.0%45.95%25.17%-2.68%
Net Profit10000
EPS in Rs1.490.070.050.050.20

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...